Research programme: pikfyve inhibitors - Verge Genomics
Alternative Names: PIKfyve inhibitors - Verge GenomicsLatest Information Update: 06 Sep 2021
At a glance
- Originator Verge Genomics
- Class Antivirals; Small molecules
- Mechanism of Action PIKFYVE protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections